Company News

23rd of May 2012
Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters Into Negotiations With Global Pharmaceutical Company (Click herer for PDF)

26th of March 2012
Successful Milestone of PD-protec™, Phase I/II "last patient out"

12th of March 2012
Mr. Peter C. Weilguni appointed as CEO, Focus on Business Development, new (Strategic) Alliances and Funding

24th of Jan. 2012
Merger between Zytoprotec and H2i-Help to Innovate GmbH

28th of Oct. 2011
Increase in capital stock by EUR 1,5 Mill.

21rst of Oct. 2011
Was awarded a Best Free Communication Prize at EURO PD in Birmingham www.meduniwien.ac.at

14th of Oct. 2011
Vienna Technology Promotion Fund ZIT to support Zytoprotec

29th of Sep. 2011
Zytoprotec raises EUR 1 Mill. as a silent partnership

24th of Aug. 2011
Robert Ochmanski appointed CEO

1rst of June 2011
Zytoprotec begins Phase I/II Clinical Trial with PD-protec™

26th of May 2011
Zytoprotec and Baxter Industrial Partners in EU Research Program “EuTRiPD”